US BROKER MOVES: QCOM upgraded at Loop Capital and Wells Fargo; OWL downgraded at Deutsche Bank

The upgrades for Qualcomm (QCOM) signify growing confidence in its prospects, moving from hold to buy by Loop Capital and from underweight to equal weight by Wells Fargo.

Newsquawk StaffPublished On the live feed at 10 more headlines followed before this page went public
Newsquawk headlinesUTC

EU Commission is reportedly on the 15th of April to propose legislation to phase out the remaining Russian oil imports, according to a draft document

Novo Nordisk (NOVOB DC) announces significant reduction in US list price for Wegovy, Ozempic, and Rybelsus, building on continued efforts to expand access

US BROKER MOVES: QCOM upgraded at Loop Capital and Wells Fargo; OWL downgraded at Deutsche Bank

US PRE-MARKET MOVERS: AMD/META/NVDA, KEYS, HD, KDP, WBD, PYPL, JPM, FANG, NVO/LLY, HIMS

Iranian Defense Minister says if war is imposed, they will give the enemy an "unforgettable lesson"

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

UPGRADES

  • Allurion Technologies (ALUR) upgraded from Neutral to Buy at Chardan; PT USD 3
  • Booking Holdings (BKNG) upgraded from Equal Weight to Overweight at Morgan Stanley; PT USD 5,500 (from USD 6,150)
  • Domino’s Pizza (DPZ) upgraded from Neutral to Overweight at JPMorgan; PT USD 450 (from USD 460)
  • Fox Corp (FOXA) upgraded from Neutral to Buy at Seaport Global; PT USD 64
  • Freshpet (FRPT) upgraded from Equal Weight to Overweight at Morgan Stanley; PT USD 90 (from USD 71)
  • Genuine Parts Company (GPC) upgraded from Market Perform to Strong Buy at Raymond James; PT USD 145
  • PPL Corp (PPL) upgraded from Equal Weight to Overweight at Barclays; PT USD 40 (from USD 37)
  • Qualcomm (QCOM) upgraded from Hold to Buy at Loop Capital
  • Qualcomm (QCOM) upgraded from Underweight to Equal Weight at Wells Fargo; PT USD 150 (from USD 135)
  • Vir Biotechnology (VIR) upgraded from Outperform to Strong Buy at Raymond James; PT USD 19 (from USD 12)

DOWNGRADES

  • Arcellx (ACLX) downgraded from Buy to Hold at Stifel; PT USD 115 (from USD 127)
  • Arcellx (ACLX) downgraded from Buy to Neutral at UBS; PT USD 115 (from USD 100)
  • Afya (AFYA) downgraded from Buy to Neutral at BofA Securities; PT USD 17 (from USD 22)
  • Backblaze (BLZE) downgraded from Buy to Hold at Craig-Hallum; PT USD 4.50
  • Boston Properties (BXP) downgraded from Outperform to Neutral at Mizuho; PT USD 62 (from USD 79)
  • Cable One (CABO) downgraded from Neutral to Underperform at BNP Paribas Exane
  • Comcast (CMCSA) downgraded from Neutral to Underperform at BNP Paribas Exane
  • DT Midstream (DTM) downgraded from Buy to Hold at Stifel; PT USD 137 (from USD 121)
  • Enhabit (EHAB) downgraded from Buy to Neutral at UBS; PT USD 13.80 (from USD 12)
  • GATX (GATX) downgraded from Buy to Neutral at Citi; PT USD 210 (from USD 197)
  • Gossamer Bio (GOSS) downgraded from Outperform to Market Perform at Leerink; PT USD 1 (from USD 6)
  • Gossamer Bio (GOSS) downgraded from Outperform to Neutral at Wedbush; PT USD 1
  • Gossamer Bio (GOSS) downgraded from Overweight to Underweight at Barclays; PT USD 0.30 (from USD 9)
  • Kilroy Realty (KRC) downgraded from Neutral to Underperform at Mizuho; PT USD 29 (from USD 37)
  • Cheniere Energy (LNG) downgraded from Overweight to Equal Weight at Morgan Stanley; PT USD 236 (from USD 258)
  • Blue Owl Capital (OWL) downgraded from Buy to Hold at Deutsche Bank; PT USD 10 (from USD 15)
  • Preferred Bank (PFBC) downgraded from Buy to Neutral at Janney; PT USD 100

INITIATIONS

  • Abivax (ABVX) initiated at Underperform at Wedbush; PT USD 110
  • Acadia Pharmaceuticals (ACAD) initiated at Outperform at Wolfe Research; PT USD 33
  • Alkermes (ALKS) initiated at Outperform at Wolfe Research; PT USD 45
  • Apollo Global Management (APO) initiated at Sector Perform at RBC Capital
  • Ares Management (ARES) initiated at Outperform at RBC Capital; PT USD 173
  • Axsome Therapeutics (AXSM) initiated at Outperform at Wolfe Research; PT USD 230
  • Bloom Energy (BE) initiated at Neutral at Citi; PT USD 162
  • Blackstone (BX) initiated at Outperform at RBC Capital; PT USD 179
  • Carlyle Group (CG) initiated at Outperform at RBC Capital; PT USD 67
  • Centessa Pharmaceuticals (CNTA) initiated at Outperform at Wolfe Research; PT USD 40
  • Denali Therapeutics (DNLI) initiated at Peerperform at Wolfe Research
  • Eupraxia Pharmaceuticals (EPRX) initiated at Buy at Bloom Burton; PT USD 14
  • Eagle Materials (EXP) initiated at Sector Perform at RBC Capital; PT USD 208
  • Grindr (GRND) initiated at Equal Weight at Morgan Stanley; PT USD 14
  • KKR (KKR) initiated at Outperform at RBC Capital; PT USD 137
  • Neurocrine Biosciences (NBIX) initiated at Outperform at Wolfe Research; PT USD 160
  • Preferred Bank (PFBC) initiated at Neutral at Brean Capital; PT USD 100
  • Picsart (PICS) initiated at Buy at BofA Securities; PT USD 27
  • Praxis Precision Medicines (PRAX) initiated at Outperform at Wolfe Research; PT USD 500
  • uniQure (QURE) initiated at Peerperform at Wolfe Research
  • SailPoint (SAIL) initiated at Outperform at FBN Securities; PT USD 18
  • Scinai Immunotherapeutics (SCNX) initiated at Buy at Maxim Group; PT USD 1.50
  • Sionna Therapeutics (SION) initiated at Market Outperform at Citizens; PT USD 63
  • Stoke Therapeutics (STOK) initiated at Outperform at Wolfe Research; PT USD 40
  • TPG (TPG) initiated at Outperform at RBC Capital; PT USD 59
  • Tyra Biosciences (TYRA) initiated at Overweight at Cantor Fitzgerald
  • Venture Global (VG) initiated at Underweight at Morgan Stanley; PT USD 8
  • Cactus (WHD) initiated at Overweight at Piper Sandler; PT USD 73
  • Xenon Pharmaceuticals (XENE) initiated at Outperform at Wolfe Research; PT USD 60
Context

This dual upgrade could reflect improving fundamentals or recent performance, potentially impacting sentiment across the semiconductor sector. Conversely, Blue Owl Capital’s downgrade highlights increasing caution and could indicate sector volatility, warranting attention for its broader implications on related stocks.

Related headlines

The whole workspace, free to try.

Try it free